SEC 13F Intelligence

Cvi Holdings, LLC / SRNE

Cvi Holdings, LLC’s Sorrento Therapeutics In Position

Does Cvi Holdings, LLC own Sorrento Therapeutics In (SRNE)? Not currently — the last reported position was 1.40M shares worth $4M in Q3 2019; the fund’s latest 13F (Q2 2024) no longer reports it.

Position Value
$4M
Q3 2019
Shares
1.40M
% of Portfolio
+2.85%
Quarters Held
2
position exited

Position History SRNE

Reported value by quarter
Q2 ’19: $7MQ2 ’19Q3 ’19: $4MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20191.40M$4M+2.85%
Q2 20192.80M$7M+4.35%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cvi Holdings, LLC’s full portfolio or all institutional holders of SRNE.